• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Public Health . The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan

tetano

Editor, Senior Moderator
J Infect Public Health


. 2024 Sep 29;17(11):102556.
doi: 10.1016/j.jiph.2024.102556. Online ahead of print. The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan

Jih-Jin Tsai[SUP] 1 [/SUP], Shyh-Shin Chiou[SUP] 2 [/SUP], Po-Chih Chen[SUP] 3 [/SUP], Chun-Hong Chen[SUP] 4 [/SUP], Ping-Chang Lin[SUP] 5 [/SUP], Ching-Yi Tsai[SUP] 5 [/SUP], Wan-Long Chuang[SUP] 6 [/SUP], Shang-Jyh Hwang[SUP] 7 [/SUP], Inn-Wen Chong[SUP] 8 [/SUP], Li-Teh Liu[SUP] 9 [/SUP]



Affiliations
Abstract

Background: Omicron, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, entered Taiwan at the end of 2021. The Taiwanese government ended its "zero-COVID" policy in March 2022. Multiple coronavirus disease 2019 (COVID-19) outbreaks began in April 2022. We monitored the replacement of Omicron subvariants after BA.1/BA.2 and analyzed their correlation with COVID-19 outbreaks.
Methods: We collected SARS-CoV-2 real-time qRTPCR-positive nasopharyngeal swabs from Kaohsiung Medical University Hospital (KMUH), Kaohsiung City, Taiwan, and performed sequencing for specimens exhibiting a cytopathic effect in Vero E6 cells to determine their clades and lineages. We analyzed the medical records of COVID-19 patients and identified hospitalization risk factor(s). We retrieved SARS-CoV-2 sequences identified in Taiwan from GISAID and analyzed their correlation with COVID-19 data from the Taiwan Centers for Disease Control.
Results: We analyzed the phylogenesis of KMUH-47 to KMUH-104 (SARS-CoV-2 isolates identified herein) and all of the Omicron subvariants from BA.5 to XBB.1 (n = 1930). Age and comorbidities were hospitalization risk factors. Men generally exhibited a greater fatality rate than women. COVID-19-related deaths predominantly occurred in individuals over 70 years old. The COVID-19-related case fatality rate increased as nucleotide (NT) and amino acid (AA) substitutions increased. The number of COVID-19-related cases and deaths progressively decreased with each outbreak between August 2022 and October 2023.
Conclusion: Hospitalization was associated with age and the presence of comorbidities. COVID-19-related fatality was linked to sex, age, and the accumulation of NT and AA substitutions in emerging Omicron subvariants.

Keywords: Age; COVID-19; Fatality; Omicron subvariant; Sex; Vaccination.

 
Back
Top Bottom